Neuroprotective Properties of Standardized Extracts of Hypericum perforatum on Rotenone Model of Parkinson’s Disease

E-ISSN： 1996-3181|12|5|665-679

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.12, Iss.5, 2013-08, pp. : 665-679

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neuroprotective Strategies for Parkinson's Disease

Current Neuropharmacology, Vol. 2, Iss. 3, 2004-01 ,pp. : 309-322

Bentham Science Publishers

Access to resources Recommend Favorite

Physico-chemical interactions between extracts of Hypericum perforatum L. and drugs

By Groning R. Breitkreutz J. Muller R.S.

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 56, Iss. 2, 2003-09 ,pp. : 231-236

Elsevier

Access to resources Recommend Favorite

Antidepressant-Like Components of Hypericum perforatum Extracts: An Overview of Their Pharmacokinetics and Metabolism

Current Drug Metabolism, Vol. 6, Iss. 6, 2005-12 ,pp. : 531-543

Bentham Science Publishers

Access to resources Recommend Favorite

Potential Therapeutic Properties of Green Tea Polyphenols in Parkinsons Disease

By Pan T. Jankovic J. Le W.

Drugs & Aging, Vol. 20, Iss. 10, 2003-01 ,pp. : 711-721

Adis International

Access to resources Recommend Favorite

Monoamine Oxidase Inhibitors Extracted from Tobacco Smoke as Neuroprotective Factors for Potential Treatment of Parkinson’s Disease

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 6, 2015-01 ,pp. : 777-785

Bentham Science Publishers

Access to resources Recommend Favorite